Abstract

Recent findings suggest that the ribosome itself modulates gene expression. However, whether ribosomes change composition across cell types or control cell fate remains unknown. Here, employing quantitative mass spectrometry during human embryonic stem cell differentiation, we identify dozens of ribosome composition changes underlying cell fate specification. We observe upregulation of RPL10A/uL1-containing ribosomes in the primitive streak followed by progressive decreases during mesoderm differentiation. An Rpl10a loss-of-function allele in mice causes striking early mesodermal phenotypes, including posterior trunk truncations, and inhibits paraxial mesoderm production in culture. Ribosome profiling in Rpl10a loss-of-function mice reveals decreased translation of mesoderm regulators, including Wnt pathway mRNAs, which are also enriched on RPL10A/uL1-containing ribosomes. We further show that RPL10A/uL1 regulates canonical and non-canonical Wnt signaling during stem cell differentiation and in the developing embryo. These findings reveal unexpected ribosome composition modularity that controls differentiation and development through the specialized translation of key signaling networks.

How ribosomes differ in composition and function to regulate gene expression is poorly understood. Here, the authors show that ribosome composition changes during stem cell differentiation and identify a ribosomal protein that regulates production of the mesoderm lineage.

Details

Title
A stem cell roadmap of ribosome heterogeneity reveals a function for RPL10A in mesoderm production
Author
Genuth, Naomi R. 1   VIAFID ORCID Logo  ; Shi, Zhen 2 ; Kunimoto, Koshi 3 ; Hung, Victoria 4   VIAFID ORCID Logo  ; Xu, Adele F. 4   VIAFID ORCID Logo  ; Kerr, Craig H. 4 ; Tiu, Gerald C. 4 ; Oses-Prieto, Juan A. 5   VIAFID ORCID Logo  ; Salomon-Shulman, Rachel E. A. 6 ; Axelrod, Jeffrey D. 3   VIAFID ORCID Logo  ; Burlingame, Alma L. 5   VIAFID ORCID Logo  ; Loh, Kyle M. 6   VIAFID ORCID Logo  ; Barna, Maria 4   VIAFID ORCID Logo 

 Stanford University, Department of Genetics, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Department of Biology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
 Stanford University, Department of Genetics, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Genentech Inc, South San Francisco, USA (GRID:grid.418158.1) (ISNI:0000 0004 0534 4718) 
 Stanford University, Department of Pathology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
 Stanford University, Department of Genetics, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
 University of California San Francisco, Department of Pharmaceutical Chemistry, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 Stanford University, Department of Developmental Biology, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2715621457
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.